Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease
Parkinson's disease is one of the most common neurodegenerative disorders in elderly age. One of the mechanisms involved in the neurodegeneration appears related to the aggregation of the presynaptic protein alpha synuclein (α-syn) into toxic oligomers and fibrils. To date, no highly effective...
Saved in:
Main Authors: | Serena Vittorio (Author), Ilenia Adornato (Author), Rosaria Gitto (Author), Samuel Peña-Díaz (Author), Salvador Ventura (Author), Laura De Luca (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson's Disease
by: Samuel Peña-Díaz, et al.
Published: (2023) -
Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
by: Hayate Javed, et al.
Published: (2019) -
The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease
by: Kaixia Yang, et al.
Published: (2024) -
Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease
by: Jay Gupta, et al.
Published: (2023) -
Novel DNA Aptamers for Parkinson's Disease Treatment Inhibit α-Synuclein Aggregation and Facilitate its Degradation
by: Yuan Zheng, et al.
Published: (2018)